Published in Cancer Cell on July 04, 2014
Autophagy in malignant transformation and cancer progression. EMBO J (2015) 2.67
Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol (2016) 1.83
Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol (2014) 1.57
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. Cancer Cell (2016) 1.47
Autophagy in cellular metabolism and cancer. J Clin Invest (2015) 1.17
IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. J Exp Med (2015) 1.16
The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16
New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med (2015) 1.12
Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A (2015) 1.10
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res (2015) 1.06
Serine and one-carbon metabolism in cancer. Nat Rev Cancer (2016) 1.06
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells. Cancer Cell (2016) 0.93
Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade. Cell Rep (2015) 0.92
p62 in Cancer: Signaling Adaptor Beyond Autophagy. Cell (2016) 0.88
The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis. Front Oncol (2014) 0.87
A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells. Autophagy (2015) 0.87
Recent insights into the function of autophagy in cancer. Genes Dev (2016) 0.86
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis. Oncotarget (2016) 0.85
Molecular pathways: trafficking of metabolic resources in the tumor microenvironment. Clin Cancer Res (2015) 0.85
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ (2016) 0.84
Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev (2015) 0.83
p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Lett (2016) 0.82
Metabolic asymmetry in cancer: a "balancing act" that promotes tumor growth. Cancer Cell (2014) 0.81
Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM. Nat Commun (2016) 0.81
AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer. Oncotarget (2015) 0.81
miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo. Oncotarget (2015) 0.80
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent. Oncotarget (2015) 0.80
A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer. J Pharmacol Exp Ther (2015) 0.80
The Unfolded Protein Response Plays a Predominant Homeostatic Role in Response to Mitochondrial Stress in Pancreatic Stellate Cells. PLoS One (2016) 0.79
Inflammation and skeletal metastasis. Bonekey Rep (2015) 0.79
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program. Stem Cells (2016) 0.78
p62 loss reprograms stromal metabolism to promote tumor growth. Cancer Discov (2014) 0.77
Autophagy and Tumor Metabolism. Cell Metab (2017) 0.77
P62: An emerging oncotarget for osteolytic metastasis. J Bone Oncol (2016) 0.76
Expanding perspectives on the significance of mitophagy in cancer. Semin Cancer Biol (2017) 0.76
Regulation of glucose metabolism by p62/SQSTM1 through HIF1α. J Cell Sci (2016) 0.75
microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma. J Steroid Biochem Mol Biol (2017) 0.75
p62/SQSTM1 cooperates with hyperactive mTORC1 to regulate glutathione production, maintain mitochondrial integrity and promote tumorigenesis. Cancer Res (2017) 0.75
Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC. Am J Cancer Res (2017) 0.75
Nutrient stress revamps cancer cell metabolism. Cell Res (2015) 0.75
Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression. Front Oncol (2016) 0.75
Glucose Metabolism in the Progression of Prostate Cancer. Front Physiol (2017) 0.75
Autophagy and Inflammatory Response in the Tumor Microenvironment. Int J Mol Sci (2017) 0.75
Autophagy-dependent regulation of tumor metastasis by myeloid cells. PLoS One (2017) 0.75
Metabolism shapes the tumor microenvironment. Curr Opin Cell Biol (2017) 0.75
P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions. Oncotarget (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Inflammation and cancer. Nature (2002) 53.78
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
Immunity, inflammation, and cancer. Cell (2010) 28.27
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Inflammation in prostate carcinogenesis. Nat Rev Cancer (2007) 9.08
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol (2002) 8.89
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
MYC on the path to cancer. Cell (2012) 8.65
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol (2007) 7.20
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol (2010) 6.95
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell (2010) 6.33
p62 at the crossroads of autophagy, apoptosis, and cancer. Cell (2009) 5.97
Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83
Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science (2010) 5.44
The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell (2008) 4.48
Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature (2009) 4.21
Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol (2008) 4.05
Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci (2006) 3.50
p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell (2011) 3.46
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature (2010) 3.24
Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer (2013) 3.23
Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A (2010) 3.03
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell (2012) 2.94
Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 2.90
Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr Opin Genet Dev (2009) 2.85
Regulation of TFEB and V-ATPases by mTORC1. EMBO J (2011) 2.84
Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev (2012) 2.82
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest (2009) 2.66
The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell (2004) 2.65
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol (2011) 2.64
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.55
Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol (1998) 2.35
IL-6 involvement in epithelial cancers. J Clin Invest (2007) 2.29
p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene (2003) 2.17
Autophagy-mediated tumor promotion. Cell (2013) 2.08
Polarized immune responses differentially regulate cancer development. Immunol Rev (2008) 1.95
p62: a versatile multitasker takes on cancer. Trends Biochem Sci (2012) 1.93
Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol (2005) 1.61
Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci (2012) 1.54
Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat Med (2010) 1.52
Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol (1986) 1.51
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer (2007) 1.49
The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer (2012) 1.46
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell (2013) 1.44
Understanding metabolic regulation and its influence on cell physiology. Mol Cell (2013) 1.43
The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene (2012) 1.34
Feedback on fat: p62-mTORC1-autophagy connections. Cell (2011) 1.31
Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology (2008) 1.24
The atypical PKCs in inflammation: NF-κB and beyond. Immunol Rev (2012) 1.17
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. Cancer Cell (2013) 1.15
Exploiting tumor metabolism: challenges for clinical translation. J Clin Invest (2013) 1.10
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol (2011) 1.07
Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery. Cell Cycle (2013) 1.07
Targeting the tumor stroma as a novel therapeutic approach for prostate cancer. Adv Pharmacol (2012) 0.96
c-Myc phosphorylation by PKCζ represses prostate tumorigenesis. Proc Natl Acad Sci U S A (2013) 0.96
Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia (1997) 0.95
Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther (2006) 0.90